[Serological antibodies comparison of a hepatitis E outbreak]
- PMID: 16201469
[Serological antibodies comparison of a hepatitis E outbreak]
Abstract
Objective: To compare the serological characters of an outbreak of hepatitis E and evaluate sensitivity and specificity of anti-HEV E2-IgM.
Methods: The sera collected from the employees of an outbreak unit were detected for anti-HEV E2-IgM and IgG, and the serum samples from a neighboring department were used as control. The results detected with anti-HEV E2-IgM, IgG and Genelab anti-HEV IgM, IgG in some samples were compared.
Results: The positive rate of anti-HEV E2-IgM in the control group was 0.11%. The results between the positive and the negative samples can be distinguished easily. The specificity of anti-HEV E2-IgM is about 99.89%. The positive rate of anti-HEV E2-IgM in outbreak stricken population was 8.66%, significantly higher than that in the control group (P < 0.001). The results from HEV patients' serial samples in the outbreak unit showed that the anti-HEV E2-IgM titer was high 30-60 days after the infected and then declined clearly. The positivity seemed unrelated to neither sex nor age. Among the 115 positive to anti-HEV E2-IgM, 27 were negative to Genelab anti-HEV IgG, the fact indicated a rather high risk of misdiagnosis of about 23.48%. In the 179 randomized samples of the control group, the positive rate of Genelabs anti-HEV IgG was about 11.17%. In 110 samples for the positive anti-HEV E2-IgM, the positive ratio of Genelabs anti-HEV IgG was about 76.36%, and that of Genelabs anti-HEV IgM only 69.09%. There were 16 samples negative for both Genelabs anti-HEV IgG and IgM. The ratio of the difference between the Genelabs anti-HEV IgG and IgM was about 25.45%.
Conclusion: The specificity of anti-HEV E2-IgM was about 99%, and false positive rate was low. The sensitivity of anti-HEV E2-IgM in acute hepatitis E infection was 25%-30% higher than that of Genelabs anti-HEV IgM,IgG. The infected persons in the outbreak unit can be preferably distinguished from the non-infected persons by anti-HEV E2-IgM. Anti-HEV E2-IgM can image the characters of the outbreak of HEV and played a great role in the control of outbreak and in the early diagnosis for hepatitis E.
Similar articles
-
[Serological characteristics of a hepatitis E outbreak].Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2003 Dec;17(4):361-4. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2003. PMID: 15340553 Chinese.
-
Evaluation of human (genotype 1) and swine (genotype 4)-ORF2-based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections.J Viral Hepat. 2007 Jun;14(6):435-45. doi: 10.1111/j.1365-2893.2006.00801.x. J Viral Hepat. 2007. PMID: 17501765
-
[IgM to recombinant antigen E2 of HEV envelope protein is a sensitive and specific serological marker in diagnosis of acute hepatitis E].Zhonghua Gan Zang Bing Za Zhi. 2005 Aug;13(8):590-3. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 16092982 Chinese.
-
Serological diagnosis of jaundice epidemics in India.Southeast Asian J Trop Med Public Health. 1998 Sep;29(3):497-502. Southeast Asian J Trop Med Public Health. 1998. PMID: 10437945 Review.
-
Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity.Rev Med Virol. 2012 Sep;22(5):339-49. doi: 10.1002/rmv.1719. Epub 2012 May 30. Rev Med Virol. 2012. PMID: 22645002 Review.
Cited by
-
Postinfantile giant cell hepatitis due to hepatitis E virus along with the presence of autoantibodies.Dig Dis Sci. 2007 Dec;52(12):3521-3. doi: 10.1007/s10620-006-9698-8. Epub 2007 Apr 5. Dig Dis Sci. 2007. PMID: 17410455 No abstract available.